Signature Resources Capital Management, LLC Gilead Sciences, Inc. Transaction History
Signature Resources Capital Management, LLC
- $112 Billion
- Q4 2024
A detailed history of Signature Resources Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Signature Resources Capital Management, LLC holds 143 shares of GILD stock, worth $16,300. This represents 0.01% of its overall portfolio holdings.
Number of Shares
143
Previous 143
-0.0%
Holding current value
$16,300
Previous $12 Million
10.18%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,100Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.17 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.88 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.61 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $143B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...